Recent Trends in the Integrated Management of Cutaneous Squamous Cell Carcinoma
Dermato · 2022
DOI: 10.3390/dermato2030007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Dermato, 2022. Verfasst von Piyu Parth Naik. Die Arbeit nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cutaneous squamous cell carcinoma (cSCC) is one of the most prevalent neoplasms worldwide. Important risk factors for cSCC include sun exposure, immunosuppression, pale skin, and aging. White people are more likely to develop cSCC, and men are more affected than women. In advanced cases, surgery and/or radiotherapy are no longer effective. Due to a historical lack of treatment options, some medications have been used in these patients without sufficient recommendation. There is an urgent need to identify patients at an increased risk of recurrence and spread early for timely diagnosis and treatment. Despite extensive data on the high-risk features and prognostication, considerable variation remains globally regarding high-risk cSCC and the delivery of oncology services. The current comprehensive review evaluated and summarized contemporary knowledge of various management options for cSCC to simplify the integrated treatment plans.
Zitieren
APA
Naik, P. P. (2022). Recent Trends in the Integrated Management of Cutaneous Squamous Cell Carcinoma. Dermato. https://doi.org/10.3390/dermato2030007
Vancouver
Naik PP. Recent Trends in the Integrated Management of Cutaneous Squamous Cell Carcinoma. Dermato. 2022. doi:10.3390/dermato2030007
BibTeX
@article{Naik2022,
author = {Naik, Piyu Parth},
title = {Recent Trends in the Integrated Management of Cutaneous Squamous Cell Carcinoma},
journal = {Dermato},
year = {2022},
doi = {10.3390/dermato2030007}
}
EUVIMED